Strides Pharma Science Ltd (BOM:532531)
ā‚¹ 1634.5 39.35 (2.47%) Market Cap: 150.72 Bil Enterprise Value: 170.45 Bil PE Ratio: 64.92 PB Ratio: 6.62 GF Score: 68/100

Q4 2021 Strides Pharma Science Ltd Earnings Call Transcript

May 27, 2021 / 11:00AM GMT
Release Date Price: ā‚¹807.35 (-0.65%)
Abhishek Singhal

Good afternoon, and thank you for joining us today for Strides earnings call for fourth quarter and full year ended financial year 2021. Today, we have with us Arun, Founder and Non-Executive Chairman; Dr. Ananth, Managing Director and CEO; and Badree, ED and Finance -- ED Finance and Group CFO, to share the highlights of the business and financials for the quarter. I hope you've gone through our results release and the quarterly investor presentation, which have been uploaded on our website. The transcript for this call will be available in a week's time on the company's website. Please note that today's discussion may be forward-looking in nature and must be viewed in relation to the risks pertaining to our business. After the end of this call, in case you have any further questions, please feel free to reach out to the Investor Relations team. I now hand over the call to Arun to make the opening comments.

Arun Kumar Pillai
Strides Pharma Science Limited - Founder & Non-Executive Chairman

Thank you, Abhishek. Good evening, everybody, and thanks

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot